Company: ACBM
Filing Date: 2025-07-18
Form Type: 10-K
Source: 0001640334-25-001245
Chunk: 93

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-18
Form: 10-K
Item: Item 12
Chunk 93
---
The following table provides information as to shares of common stock beneficially owned as of July 15, 2025, by:

·Each director;·Each current officer named in the summary compensation table;·Each person owning of record or known by us, based on information provided to us by the persons named below, at least 5% of our common stock; and·All directors and officers as a group.

For purposes of the following table, “beneficial ownership” means the sole or shared power to vote, or to direct the voting of, a security, or sole or shared investment power with respect to a security, or any combination thereof, and the right to acquire such power (for example, through the exercise of options, warrants or convertible securities) within 60 days of July 15, 2025. None of the named beneficial owners held any options, warrants or convertible securities at July 15, 2025.

Name and Address of Beneficial Owner Amountand NatureofBeneficial Ownership  % of Class        Pao-Chi Chu 2F, No. 356, Dunhua S. Road, Da’an DistTaipei City 106, Taiwan, ROC  30,000,000   49.97%         All officers and directors as a group (one individual)  30,000,000   49.97%

 25Table of Contents

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE

Related Party Transactions

At December 31, 2023 and 2022, we owed $1,100 to our chief executive officer for non-interest-bearing advances made to us or on our behalf. These advances are due on demand.

During the years ended December 31, 2023 and 2022, a minority stockholder advanced $0 and $55,000 and paid expenses of $9,970 and $3,085 on our behalf, all of which was outstanding on December 31, 2023.

At December 31, 2023 and 2022, we owed $87,696 and $77,726 to the minority stockholder referred to in the preceding paragraph for non-interest-bearing advances made to or on our behalf, respectively. These advances are due on demand.

We have imputed interest at the rate of 4% on the advances made to or on our behalf. Imputed interest amounted to $3,206 and $1,706,